Suchergebnisse
LogicBio Therapeutics: ContextLogic Unveils $850M gChem Specialty Chemicals Acquisition
Key Points
- Interested in LogicBio Therapeutics, Inc.? Here are five stocks we like better.
- ContextLogic plans to acquire gChem for $850 million in cash, its second operating-business acquisition
